1. Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial. (1st December 2016) Authors: Al‐Sawaf, Othman; Fischer, Kirsten; Herling, Carmen D.; Ritgen, Matthias; Böttcher, Sebastian; Bahlo, Jasmin; Elter, Thomas; Stilgenbauer, Stephan; Eichhorst, Barbara F.; Busch, Raymonde; Elberskirch, Ute; Abenhardt, Wolfgang; Kneba, Michael; Hallek, Michael; Wendtner, Clemens‐Martin Journal: European journal of haematology Issue: Volume 98:Number 3(2017:Mar.) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bendamustine followed by obinutuzumab and venetoclax in chronic lymphocytic leukaemia (CLL2-BAG): primary endpoint analysis of a multicentre, open-label, phase 2 trial. Issue 9 (September 2018) Authors: Cramer, Paula; von Tresckow, Julia; Bahlo, Jasmin; Robrecht, Sandra; Langerbeins, Petra; Al-Sawaf, Othman; Engelke, Anja; Fink, Anna-Maria; Fischer, Kirsten; Tausch, Eugen; Seiler, Till; Fischer von Weikersthal, Ludwig; Hebart, Holger; Kreuzer, Karl-Anton; Böttcher, Sebastian; Ritgen, Matthias; K... Journal: Lancet oncology Issue: Volume 19:Issue 9(2018) Page Start: 1215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy and safety of obinutuzumab combined with fludarabine and cyclophosphamide (FCG) or bendamustine (BG) in relapsed or refractory CLL patients followed by maintenance therapy with obinutuzumab for responding patients. Issue 2 (28th January 2023) Authors: Kutsch, Nadine; Holmes, Emily Eva; Robrecht, Sandra; Schüler, Gudrun; Vehling-Kaiser, Ursula; Decker, Thomas; Müller-Hagen, Sigrun; Heinisch, Karin; Böttcher, Sebastian; Ritgen, Matthias; Kreuzer, Karl-Anton; Stilgenbauer, Stephan; Fink, Anna Maria; Fischer, Kirsten; Eichhorst, Barbara; Hallek, M... Journal: Leukemia & lymphoma Issue: Volume 64:Issue 2(2023) Page Start: 478 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Issue 4 (8th April 2022) Authors: Kutsch, Nadine; Pallasch, Christian; Tausch, Eugen; Böhme, Volkmar; Ritgen, Matthias; Liersch, Rüdiger; Wacker, Alexander; Jacobs, Georg; Trappe, Ralf Ulrich; Dreger, Peter; Fischer, Kirsten; Fink, Anna-Maria; Stilgenbauer, Stephan; Zhai, Shuyan; Li, Biao; Jürgensmeier, Juliane M.; Rajakumaraswam... Journal: HemaSphere Issue: Volume 6:Issue 4(2022) Page Start: e692 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia. Issue 6 (25th June 2022) Authors: Kutsch, Nadine; Pallasch, Christian; Decker, Thomas; Hebart, Holger; Chow, Kai Uwe; Graeven, Ullrich; Kisro, Jens; Kroeber, Alexander; Tausch, Eugen; Fischer, Kirsten; Fink, Anna-Maria; Wendtner, Clemens-Martin; Ritgen, Matthias; Stilgenbauer, Stephan; Zhang, Danjie; Li, Biao; Jürgensmeier, Julia... Journal: HemaSphere Issue: Volume 6:Issue 6(2022) Page Start: e729 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30. (2nd January 2016) Authors: Kellner, Christian; Günther, Andreas; Humpe, Andreas; Repp, Roland; Klausz, Katja; Derer, Stefanie; Valerius, Thomas; Ritgen, Matthias; Brüggemann, Monika; van de Winkel, Jan GJ; Parren, Paul WHI; Kneba, Michael; Gramatzki, Martin; Peipp, Matthias Journal: Oncoimmunology Issue: Volume 5:Number 1(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Genes encoding members of the JAK‐STAT pathway or epigenetic regulators are recurrently mutated in T‐cell prolymphocytic leukaemia. (25th February 2016) Authors: López, Cristina; Bergmann, Anke K.; Paul, Ulrike; Murga Penas, Eva M.; Nagel, Inga; Betts, Matthew J.; Johansson, Patricia; Ritgen, Matthias; Baumann, Tycho; Aymerich, Marta; Jayne, Sandrine; Russell, Robert B.; Campo, Elias; Dyer, Martin JS; Dürig, Jan; Siebert, Reiner Journal: British journal of haematology Issue: Volume 173:Number 2(2016) Page Start: 265 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of telomere length on the outcome of allogeneic stem cell transplantation for poor‐risk chronic lymphocytic leukaemia: results from the GCLLSG CLL3X trial. (8th July 2016) Authors: Scheffold, Annika; Jebaraj, Billy Michael Chelliah; Jaramillo, Sonia; Tausch, Eugen; Steinbrecher, Daniela; Hahn, Michael; Böttcher, Sebastian; Ritgen, Matthias; Bunjes, Donald; Zeis, Matthias; Stadler, Michael; Uharek, Lutz; Scheid, Christoph; Hegenbart, Ute; Hallek, Michael; Kneba, Michael; Sch... Journal: British journal of haematology Issue: Volume 179:Number 2(2017) Page Start: 342 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Integrated epigenomic and transcriptomic analysis reveals TP63 as a novel player in clinically aggressive chronic lymphocytic leukemia. Issue 11 (15th January 2019) Authors: Papakonstantinou, Nikos; Ntoufa, Stavroula; Tsagiopoulou, Maria; Moysiadis, Theodoros; Bhoi, Sujata; Malousi, Andigoni; Psomopoulos, Fotis; Mansouri, Larry; Laidou, Stamatia; Papazoglou, Despoina; Gounari, Maria; Pasentsis, Konstantinos; Plevova, Karla; Kuci‐Emruli, Venera; Duran‐Ferrer, Marti; D... Journal: International journal of cancer Issue: Volume 144:Issue 11(2019) Page Start: 2695 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Lenalidomide maintenance after first-line therapy for high-risk chronic lymphocytic leukaemia (CLLM1): final results from a randomised, double-blind, phase 3 study. Issue 10 (October 2017) Authors: Fink, Anna Maria; Bahlo, Jasmin; Robrecht, Sandra; Al-Sawaf, Othman; Aldaoud, Ali; Hebart, Holger; Jentsch-Ullrich, Kathleen; Dörfel, Steffen; Fischer, Kirsten; Wendtner, Clemens-Martin; Nösslinger, Thomas; Ghia, Paolo; Bosch, Francesc; Kater, Arnon P; Döhner, Hartmut; Kneba, Michael; Kreuzer, Ka... Journal: Lancet Issue: Volume 4:Issue 10(2017) Page Start: e475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗